DIN 02546221 — AWIQLI 2100 UNIT
AWIQLI is a solution of Insulin icodec marketed by NOVO NORDISK CANADA INC. The full Insulin icodec monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02546221
- Brand name
- AWIQLI
- Active ingredient
- Insulin icodec
- Strength
- 2100 UNIT
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- NOVO NORDISK CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Long-acting once-weekly basal insulin analogue
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Insulin icodec products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02546213 | AWIQLI | 1050 UNIT | SOLUTION | NOVO NORDISK CANADA INC | MARKETED |
| 02546205 | AWIQLI | 700 UNIT | SOLUTION | NOVO NORDISK CANADA INC | MARKETED |